Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial

By sjmartinez • May 28, 2025

deFilippi C, Awwad A, Bloomfield GS, Weir IR, Ribaudo H, Zanni MV, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Diggs MR, Chu SM, Paradis K, MacArthur RD, Pilotto J, Marks K, Van Dam C, Wilkin A, Currier JS, Zhao S, Wiviott SD, Lu MT, Douglas PS, Grinspoon S. Risks for sudden cardiac and undetermined cause of death among people with HIV in the reprieve primary cardiovascular prevention trial. AIDS. 2025 May 23. doi: 10.1097/QAD.0000000000004243. Epub ahead of print. PMID: 40424543.

Tags: electrocardiography, HIV, Infectious Diseases, Publications, Sudden cardiac death

Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response

Feelemyer J, Ban FK, Braithwaite RS, Bhattacharya D, Caniglia EC, Justice AC, Lim JK, Re VL, Scheidell J, Rentsch CT, Khan M. Associations Between Prior[...]

Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE

Awwad A, de Filippi C, Ribaudo H, Zanni MV, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Diggs MR, Chu SM, Lu AB, Sponseller CA, Bagchi S,[...]

Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates

Bleick CR, Van Helden SR, Berti AD, Richa R, Lehman SM, Bayer AS, Rybak MJ. Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible[...]